DC-MEETINGPLAY/AVENTRI
6.1.2022 16:02:13 CET | Business Wire | Press release
Today, market leading event software companies MeetingPlay and Aventri announce that they have merged and received a growth equity investment from Sunstone Partners and Camden Partners. Combining the strengths of both companies, they will forge a new path as the dominant, full-service event software provider.
This new event software powerhouse will blend visionary technology and best-in-class service to close all gaps in the planning process, offering the most complete full-service solution for meetings and events of all sizes, from conferences of 200,000+ to meetings with less than 100 attendees. The combined company will become one of the world’s largest event technology companies, servicing customers on a global scale.
In conjunction with the merger, Eric Lochner has been named Chief Executive Officer of the new company. Eric has over 25 years of experience in building technology and technology-enabled services companies, with an impressive record of mergers and acquisitions. “We are excited to bring these two inventive companies together to create a new cutting-edge experience for the meetings and events industry,” said Lochner. “We have a strong opportunity to deepen the process of hosting in-person, hybrid and virtual events and are excited to be able to better support meeting planners and event organizers while offering a wider range of products and experiences.”
Each year, MeetingPlay and Aventri power a combined total of more than 50,000 events, service over 10,000 companies, and elevate the attendee experience for more than 7 million attendees. The unrivaled creativity, service, and ingenuity of each company will be at the forefront of their new company and brand, which will enable their enterprise customers to grow their businesses with best-in-class events of all types and sizes.
Founded in 2011, MeetingPlay is an award-winning technology pioneer, centered around creating innovative solutions for premier in-person, virtual, and hybrid events. The company is known for pushing the envelope on technology advancements and has successfully powered many of the largest, most complex global events to date across numerous industries.
Aventri is the global leader in data-driven, end-to-end event management solutions for virtual, hybrid, and in-person events. The company was founded in 2008. Today, the award-winning platform provides a suite of premium solutions for the entire event lifecycle, from venue sourcing to event marketing, registration, onsite technology, strategic meetings management, data security and privacy, and ROI reporting.
“Two great companies are coming together, leveraging secular tailwinds to increase market share and expand their innovative software capabilities to benefit top companies and brands,” said Sunstone Partners Co-Founder and Managing Director, Michael Biggee. “We’re delighted to continue partnering with them on their exciting future as one company.”
This news comes at a critical time in the meetings and events industry when planners and organizers are seeking to adopt the benefits of virtual and hybrid gatherings while using fewer software integrations. The two companies will integrate their proprietary software platforms to elevate event experiences through a robust lineup of unmatched products to leading companies in the technology, financial services, travel, hospitality, health services, and association markets. This, paired with the highest level of service, will deliver a richer experience for both planners and attendees, while setting the brand apart from competitors. Highlighted capabilities include:
- Event Marketing Website and Registration to create a seamless attendee journey from beginning to end.
- A Virtual and Hybrid Event Platform, which uses novel technology to create lifelike experiences for virtual attendees. The platform provides virtual and onsite attendees with unified engagement features like chat, Q&A, network matchmaking, and video conferencing that enables participants in the same room and across the world to connect instantly.
- A Mobile App and imaginative Onsite Event Solutions, which enrich the attendee experience start to finish, boost engagement, and deliver ROI metrics, while keeping participants safe.
Co-Founder and former MeetingPlay CEO Joe Schwinger, and Co-Founder and former MeetingPlay COO Lisa Vann will remain with the new company and undertake executive roles to continue enhancing the event technology industry and working with their valued customers. Former Aventri CEO Jim Sharpe will remain a shareholder and advisor to the new company.
For more information about MeetingPlay, visit www.meetingplay.com and follow along on Instagram , Twitter , Facebook and LinkedIn .
For more information about Aventri, visit www.aventri.com and follow along on Instagram , Twitter , Facebook and LinkedIn .
About MeetingPlay
MeetingPlay is a Washington D.C.-based technology company focused on creating groundbreaking solutions for in-person, virtual, and hybrid events. With every meeting and event, MeetingPlay creates transformative experiences that enables their customers, attendees, and sponsors to make valuable, face-to-face connections. Market-leading companies entrust MeetingPlay to solve their biggest event challenges. Learn more at meetingplay.com
.
About Aventri
Aventri is the global leader in data-driven, end-to-end event and meeting management solutions for virtual, hybrid, and in-person events. Their award-winning SaaS platform, virtual technology, and best-in-class service offerings have enabled more than 30,000 event professionals annually to plan, promote, deliver, measure, and optimize their events. Aventri’s fully integrated platform’s capabilities include virtual delivery, networking, venue sourcing, registration, marketing, logistics, onsite services, attendee engagement, and data analytics. Headquartered in the United States, the company has offices in the United Kingdom, Europe, and Asia Pacific and has delivered customer events in over 120 countries. Learn more at aventri.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005160/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
Andersen Consulting udvider sine kompetencer inden for ledelsesrekruttering med Lansdowne Executive Search18.2.2026 17:08:00 CET | Pressemeddelelse
Andersen Consulting styrker sin humancapital-praksis gennem en samarbejdsaftale med Lansdowne Executive Search, der er en Dublin-baseret virksomhed med speciale i lederrekruttering, midlertidige ledelser og bestyrelsesudnævnelser. Lansdowne Executive Search er en irisk-ejet virksomhed, der blev grundlagt i 2015, og som tilbyder C-level-ledelsesekruttering, deltidsledere og bestyrelsesplaceringer. Som en partnerdrevet boutique-virksomhed er Lansdowne kendt for, at seniorledelsen er tæt involveret i alle kundeprojekter. Virksomheden hjælper kunder med at navigere i komplekse ledelsesovergange og vækststrategier på tværs af en bred vifte af sektorer, herunder finans, byggeindustrien, nonprofit, landbrug, videregående uddannelse, den offentlige sektor samt teknologi, medier og telekommunikation. "God ledelse er afhænger af situationen, og det kræver forståelse af langt mere end blot et CV," sagde Tom Keane, der er partner hos Lansdowne Executive Search. "Samarbejdet med Andersen Consulting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom